Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in CNTX held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | MPM Oncology Impact Management LP | 10.7M | $28.0M | 0.0% | 11.623% | 2.16% |
| 2 | Nextech Invest, Ltd. | 7.4M | $19.4M | 0.0% | 8.075% | 1.37% |
| 3 | Deep Track Capital, LP | 7.4M | $19.4M | 0.0% | 8.075% | 0.40% |
| 4 | Soleus Capital Management, L.P. | 7.0M | $18.2M | β | 7.579% | 0.74% |
| 5 | Octagon Capital Advisors LP | 5.3M | $13.8M | β | 5.714% | 1.52% |
| 6 | Blue Owl Capital Holdings LP | 5.1M | $13.3M | -31.5% | 5.539% | 3.58% |
| 7 | Avidity Partners Management LP | 5.0M | $11.8M | -9.2% | 5.440% | 2.67% |
| 8 | FRANKLIN RESOURCES INC | 3.8M | $10.0M | -5.0% | 4.139% | 0.00% |
| 9 | VANGUARD CAPITAL MANAGEMENT LLC | 3.4M | $9.0M | β | 3.735% | 0.00% |
| 10 | MARSHALL WACE, LLP | 2.9M | $7.7M | +13.7% | 3.209% | 0.01% |
| 11 | TCG Crossover Management, LLC | 2.7M | $7.0M | β | 2.920% | 0.20% |
| 12 | GREAT POINT PARTNERS LLC | 2.2M | $5.9M | -52.2% | 2.436% | 1.44% |
| 13 | MILLENNIUM MANAGEMENT LLC | 1.4M | $3.7M | -45.2% | 1.550% | 0.00% |
| 14 | Squadron Capital Management LLC | 1.1M | $2.9M | β | 1.197% | 1.20% |
| 15 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.1M | $2.9M | β | 1.191% | 0.00% |
| 16 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.0M | $2.6M | β | 1.088% | 0.00% |
| 17 | Sio Capital Management, LLC | 918K | $2.4M | -31.6% | 0.999% | 0.35% |
| 18 | BlackRock, Inc. | 847K | $2.2M | -0.2% | 0.921% | 0.00% |
| 19 | GEODE CAPITAL MANAGEMENT, LLC | 604K | $1.6M | -0.8% | 0.657% | 0.00% |
| 20 | Cormorant Asset Management, LP | 530K | $1.4M | β | 0.576% | 0.07% |
| 21 | JANE STREET GROUP, LLC | 437K | $1.1M | β | 0.475% | 0.01% |
| 22 | ADAR1 Capital Management, LLC | 351K | $920K | 0.0% | 0.382% | 0.06% |
| 23 | VANGUARD FIDUCIARY TRUST CO | 341K | $894K | β | 0.371% | 0.00% |
| 24 | GOLDMAN SACHS GROUP INC | 287K | $753K | β | 0.313% | 0.00% |
| 25 | Woodline Partners LP | 250K | $655K | β | 0.272% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in CNTX β a direct measure of their conviction.
Filings activity in CNTX during Q1 2026, grouped by how each filer changed its position.
Institutions that opened a new CNTX position in Q1 2026
Institutions that fully closed their CNTX position in Q1 2026
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 58 | +38% | 150.86% | +75.85 pp | $193M | +101% |
| Q4 2025 | 42 | +14% | 75.01% | +22.69 pp | $96M | +43% |
| Q3 2025 | 37 | 7.5% | 52.32% | +17.11 pp | $67M | +49% |
| Q2 2025 | 40 | 9.1% | 35.21% | +0.98 pp | $45M | +2.9% |
| Q1 2025 | 44 | 17% | 34.23% | 25.57 pp | $44M | 43% |
| Q4 2024 | 53 | +23% | 59.80% | 27.24 pp | $76M | 31% |
| Q3 2024 | 43 | +23% | 87.04% | 2.44 pp | $111M | 2.7% |
| Q2 2024 | 35 | β | 89.48% | β | $114M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying CNTX stock.
Based on Q1 2026 13F filings, institutional ownership of Context Therapeutics Inc. stands at 150.9%, held across 58 reporting institutions.
MPM Oncology Impact Management LP is the largest reported institutional holder of CNTX, with approximately 10,679,391 shares worth $0.03B as of Q1 2026.
Yes β 3 widely-followed marquee investors appear among the top 25 institutional holders of CNTX, including MILLENNIUM MANAGEMENT LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, JANE STREET GROUP, LLC.
Our composite Smart Money Score for CNTX is 79 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
24 institutions opened new positions in CNTX during Q1 2026, while 8 fully exited. 29 added to existing positions and 5 trimmed.
CNTX institutional ownership rose by 75.85 percentage points quarter-over-quarter, with a net change of +16 holders.
The top 10 institutions account for 78.2% of all reported 13F value in CNTX, and the top 25 account for 97.4%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Context Therapeutics Inc. (CNTX) Institutional Ownership